Evaluation of ACell Hydrated Wound Dressing for Autogenous Skin Donor Sites

Status

Withdrawn

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00352729

Acronym

ACell

Enrollment

Registered

2006-07-17

Start date

2006-11-30

Completion date

2007-08-31

Last updated

2015-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burns

Keywords

Burns, ACell, Donor Site

Brief summary

The purpose of this study is to see if treating a donor site wound with the ACell dressing is as good as or better than the dressings we currently treat harvested donor sites with. This will be tested on consenting burn patients who require excision and grafting surgery for their burn wounds. Hypothesis: The mean healing time for wounds treated with the ACell dressing will be less than the mean healing time for wounds treated with the Standard of Care dressing.

Detailed description

This is a single-center, prospective, randomized, and controlled study to evaluate the effectiveness of the ACell Dressing for use as a dressing for autogenous skin donor sites compared to our current standard donor site dressing, which is currently Xeroform.

Interventions

DEVICEACell dressing

dressing

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* less than 30% total body surface area burn * burn wounds do not involve the donor site harvesting areas * requires excision and grafting of sufficient extent to justify two donor site of roughly equal size on non-dependent body surfaces. * The scheduled excision and grafting procedure is the first such operation for the subject * subject agrees to participate in follow-up evaluations

Exclusion criteria

* Critical illnesses such as those requiring ventilator support, systemic infection, or hemodynamic instability * Major acute or chronic medical illness that could affect wound healing * Cellulitis or other infection of the potential donor sites * Donor site has been previously harvested for grafting * Subjects who are pregnant * Religious objections or allergy to porcine products

Design outcomes

Primary

Measure	Time frame
The specific aim of this study is to determine if the ACell dressing is superior to the ISR Burn Center's current standard of care dressing with respect to speed of healing, patient comfort or wound cosmesis.	14 days

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026